471820 — Cellromax Science Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapNeutral

Annual balance sheet for Cellromax Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5,148	7,044	11,800	22,732	7,703
Net Total Accounts Receivable
Net Total Receivables	1,675	621	602	641	817
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12,348	13,244	17,120	28,702	14,382
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,395	5,180	5,533	3,661	3,509
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	23,994	28,530	32,827	49,100	50,908
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,796	2,610	2,353	3,154	2,764
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	2,976	2,765	2,713	4,579	3,990
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	21,018	25,765	30,115	44,522	46,918
Total Liabilities & Shareholders' Equity	23,994	28,530	32,827	49,100	50,908
Total Common Shares Outstanding